Very late thrombosis of a drug-eluting stent after discontinuation of dual antiplatelet therapy in a patient treated with both drug-eluting and bare-metal stents

Korean Circulation Journal

Volumn 39, Issue 5, 2009, Pages 205-208

  Sung, Soo Kim ^a   Myung, Ho Jeong ^a,b   Doo, Sun Sim ^a,b   Young, Joon Hong ^a,b   Ju, Han Kim ^a,b   Young, Keun Ahn ^a,b   Jung, Chaee Kang ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Platelets; Stents; Thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BARE METAL STENT; CASE REPORT; DRUG ELUTING STENT; HEART CATHETERIZATION; HUMAN; IMPLANTATION; LABORATORY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRESCRIPTION; RIGHT CORONARY ARTERY; STENT THROMBOSIS; THORAX PAIN; THROMBUS ASPIRATION;

EID: 67549146671     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2009.39.5.205     Document Type: Article

References (12)

1. Serruys PW, Degertekin M, Tanabe K, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (Randomized study with the sirolimus-eluting Velocity balloon-expandable stent in the treatment of patients with de novo native coronaiy arteiy Lesions) trial. Circulation 2002;106:798-803.
2. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymerbased paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108:788-794
3. Zhang F, Ge J, Qian J, et al. Sirolimus-eluting stents in real-world patients with ST-segment elevation acute myocardial infarction. Int Heart J 2007;48:303-311
4. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronaiy stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-678
5. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-2351
6. Bavry AA, Kumbhani DJ, Helton TJ, et al. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006;119:1056-1061
7. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029
8. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006;113:1108-1113
9. Park SH, Hong GR, Seo HS, Tahk SJ. Stent thrombosis after successful drug-eluting stent implantation. Korean Circ J 2005;35:163-171
10. Iakovou I, Schmidt T, Bonizzouni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug eliding stents. JAMA 2005;293:2126-2130
11. Flores-Rios X, Marzoa-Rivas R, Abugattás-de Torres JP, et al. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients. Am Heart J 2008;155:648-653
12. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-2591